Mezzion Pharma Co., Ltd.

CARING FOR BIG AND LITTLE HEARTS

Providing websites featuring information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals and medicine, health, wellness, and cardiac health issues; Medical testing and screening services, namely, medical diagnostic testing services and medical screening for the treatment of cardiac disease and disorders, and single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation; providing a website featuring information in the field of health and wellness; providing a website featuring medical information in the field of cardiac issues; medical testing services, namely, providing medical testing services and information in the field of the treatment of cardiac disease and disorders, and single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation for diagnostic or treatment purposes;

CARING FOR BIG AND LITTLE HEARTS

Educational services, namely, seminars in the field of pharmaceuticals, medicine, health, wellbeing, and cardiac issues and distribution of course materials in connection therewith; providing a website featuring blogs in the field of pharmaceuticals, medicine, health, wellbeing, and cardiac issues;Medical and pharmaceutical research for the treatment of cardiac disease and disorders; Medical and pharmaceutical research for the treatment of cardiac disease and disorders, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation and product development services; scientific and technological research services related thereto, namely, scientific research services for the treatment of cardiac disease and disorders, and single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation; medical testing services, namely, providing medical testing services and information in the field of the treatment of cardiac disease and disorders research, and single ventricle heart disease (SVHD) research, including SVHD subjects who have undergone Fontan Palliation; conducting clinical trials for others for medical research purposes; conducting clinical trials for others; providing a website featuring medical and scientific research information in the field of pharmaceuticals and medicine;

DISCOVERING DEVELOPING DELIVERING HOPE

Educational services, namely, seminars in the field of pharmaceuticals, medicine, health, wellbeing, and cardiac issues and distribution of course materials in connection therewith; providing a website featuring blogs in the field of pharmaceuticals, medicine, health, wellbeing, and cardiac issues;The mark consists of stylized DISCOVERING DEVELOPING DELIVERING HOPE with a dot on either side of DEVELOPING.;Color is not claimed as a feature of the mark.;Providing websites featuring information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals and medicine, health, wellness, and cardiac health issues; Medical testing and screening services, namely, medical diagnostic testing services and medical screening for the treatment of cardiac disease and disorders, and single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation; providing a website featuring information in the field of health and wellness; providing a website featuring medical information in the field of cardiac issues; medical testing services, namely, providing medical testing services and information in the field of the treatment of cardiac disease and disorders, and single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation for diagnostic or treatment purposes;DISCOVERING DEVELOPING;Medical and pharmaceutical research for the treatment of cardiac disease and disorders; Medical and pharmaceutical research for the treatment of cardiac disease and disorders, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation and product development services; scientific and technological research services related thereto, namely, scientific research services for the treatment of cardiac disease and disorders, and single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation; medical testing services, namely, providing medical testing services and information in the field of the treatment of cardiac disease and disorders research, and single ventricle heart disease (SVHD) research, including SVHD subjects who have undergone Fontan Palliation; for medical research purposes; conducting clinical trials for others; providing a website featuring medical and scientific research information in the field of pharmaceuticals and medicine;

JULVIO

Educational services, namely, lectures, seminars, training and classes in the field of pharmaceuticals, medicine, health, wellbeing, and cardiac issues, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation; education, namely, lectures, seminars, classes and training in the use of pharmaceuticals for cardiac and other health issues;Pharmaceutical preparations for the treatment of cardiac disease, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation; medicinal preparations for cardiac disease, namely, single ventricle heart disease (SVHD); pharmaceuticals, namely, drugs for the treatment of cardiac disease, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation;Medical testing and screening services, namely, medical diagnostic testing services and medical screening the treatment of cardiac disease, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation;Medical and pharmaceutical research for the treatment of cardiac disease, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation and development services; scientific and technological research services related thereto, namely, scientific research services for the treatment of cardiac disease, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation; medical testing and screening services, namely, providing medical testing services and information in the field of the treatment of cardiac disease, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation; conducting clinical trials for others;

JURVIGO

Educational services, namely, lectures, seminars, training and classes in the field of pharmaceuticals, medicine, health, wellbeing, and cardiac issues, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation; education, namely, lectures, seminars, classes and training in the use of pharmaceuticals for cardiac and other health issues;Pharmaceutical preparations for the treatment of cardiac disease, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation; medicinal preparations for cardiac disease, namely, single ventricle heart disease (SVHD); pharmaceuticals, namely, drugs for the treatment of cardiac disease, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation;Medical testing and screening services, namely, medical diagnostic testing services and medical screening the treatment of cardiac disease, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation; medical testing and screening services, namely, providing medical testing services and information in the field of the treatment of cardiac disease, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation for diagnostic or treatment purposes;Medical and pharmaceutical research for the treatment of cardiac disease, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation and development services; scientific and technological research services related thereto, namely, scientific research services for the treatment of cardiac disease, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation; medical testing and screening services, namely, providing medical testing services and information in the field of the treatment of cardiac disease research, namely, single ventricle heart disease (SVHD) research, including SVHD subjects who have undergone Fontan Palliation for medical research purposes; conducting clinical trials for others;

MEZZION

Pharmaceutical preparations for the treatment of diseases and disorders, Pharmaceutical preparations for the treatment of cardiac diseases and disorders; Pharmaceutical preparations for the treatment of cardiac diseases and disorders, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation; medicinal preparations for cardiac disease, namely single ventricle heart disease (SVHD); pharmaceuticals, namely, drugs for the treatment of cardiac disease, namely single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation;Medical testing and screening services, namely, medical diagnostic testing services and medical screening the treatment of cardiac disease and disorders, namely single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation;Medical and pharmaceutical research for the treatment of cardiac disease and disorders, namely single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation and development services; scientific and technological research services related thereto, namely, scientific research services for the treatment of cardiac disease, namely single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation ; medical testing services, namely, providing medical testing services and information in the field of the treatment of cardiac disease, namely single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation; conducting clinical trials for others;

MEZZION

Educational services, namely, seminars in the field of pharmaceuticals, medicine, health, wellbeing, and cardiac issues and distribution of course materials in connection therewith; providing a website featuring blogs in the field of pharmaceuticals, medicine, health, wellbeing, and cardiac issues;The word MEZZION with the O replaced with an open ended heart with a stylized image of a person therein closing the heart shape.;Pharmaceutical preparations for the treatment of diseases and disorders, Pharmaceutical preparations for the treatment of cardiac diseases and disorders; Pharmaceutical preparations for the treatment of cardiac diseases and disorders, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation; medicinal preparations for cardiac disease, namely, single ventricle heart disease (SVHD); pharmaceuticals, namely, drugs for the treatment of cardiac disease, and single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation;Color is not claimed as a feature of the mark.;Providing websites featuring information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals and medicine, health, wellness, and cardiac health issues; Medical testing and screening services, namely, medical diagnostic testing services and medical screening the treatment of cardiac disease and disorders, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation; providing a website featuring information in the field of health and wellness; providing a website featuring medical information in the field of cardiac issues; medical testing services, namely, providing medical testing services and information in the field of the treatment of cardiac disease and disorders, and single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation for diagnostic or treatment purposes;Medical and pharmaceutical research for the treatment of cardiac disease and disorders, and single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation and product development services; scientific and technological research services related thereto, namely, scientific research services for the treatment of cardiac disease and disorders, and single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation; medical testing services, namely, providing medical testing services and information in the field of the treatment of cardiac disease and disorder research, and single ventricle heart disease (SVHD) research, including SVHD subjects who have undergone Fontan Palliation for medical research purposes; conducting clinical trials for others; providing a website featuring medical and scientific research information in the field of pharmaceuticals and medicine;

MEZZION PATHWAY

Educational services, namely, seminars, and distribution of educational materials in connection therewith, all in the field of pharmaceuticals, medicine, health, wellbeing, and cardiac issues; providing a website featuring blogs and online instruction in the field of pharmaceuticals, medicine, health, wellbeing, and cardiac issues;Providing a website featuring educational information in the in the field of pharmaceuticals, medicine, health, wellbeing, and cardiac issues; medical diagnostic testing and screening services;Medical and pharmaceutical research and development services; scientific and technological research services related thereto in the field of cardiac health; conducting clinical trials for others;

MZN

Pharmaceutical preparations for the treatment of cardiac disease, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation; medicinal preparations for cardiac disease, namely, single ventricle heart disease (SVHD); pharmaceuticals, namely, drugs for the treatment of cardiac disease, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation;

SARJUDO

Educational services, namely, seminars, blogs, online instruction and distribution of educational materials therewith, all in the field of pharmaceuticals, medicine, health, wellbeing, and cardiac issues; namely training in the use of pharmaceuticals for cardiac and other health issues;Pharmaceutical preparations for the treatment of cardiac disease, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation; medicinal preparations for cardiac disease, namely, single ventricle heart disease (SVHD); pharmaceuticals, namely, drugs for the treatment of cardiac disease, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation;The wording SARJUDO has no meaning in a foreign language.;

SHAPING THE FUTURE OF SINGLE VENTRICLE HEART DISEASE (SVHD)

Educational services, namely, seminars in the field of pharmaceuticals, medicine, health, wellbeing, and cardiac issues and distribution of course materials in connection therewith; providing a website featuring blogs in the field of pharmaceuticals, medicine, health, wellbeing, and cardiac issues;Providing websites featuring information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals and medicine, health, wellness, and cardiac health issues; Medical testing and screening services, namely, medical diagnostic testing services and medical screening for the treatment of cardiac disease and disorders, and single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation; providing a website featuring information in the field of health and wellness; providing a website featuring medical information in the field of cardiac issues; medical testing services, namely, providing medical testing services and information in the field of the treatment of cardiac disease and disorders;Medical and pharmaceutical research for the treatment of cardiac disease and disorders; Medical and pharmaceutical research for the treatment of cardiac disease and disorders, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation and product development services; scientific and technological research services related thereto, namely, scientific research services for the treatment of cardiac disease and disorders, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation; Medical and pharmaceutical research for the treatment of cardiac disease and disorders, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation; conducting clinical trials for others;

TREATING ONE VENTRICLE AT A TIME

Educational services, namely, seminars, blogs, online instruction and distribution of educational materials therewith, all in the field of pharmaceuticals, medicine, health, wellbeing, and cardiac issues;Providing a website featuring educational information in the in the field of pharmaceuticals, medicine, health, wellbeing, and cardiac issues; medical diagnostic testing and screening services;Medical and pharmaceutical research and development services; scientific and technological research services related thereto in the field of the treatment of cardiac disease and disorders, and single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation; medical testing and screening services for medical research purposes; conducting clinical trials for others;

WEKORO

Educational services, namely, seminars, blogs, online instruction and distribution of educational materials therewith, all in the field of pharmaceuticals, medicine, health, wellbeing, and cardiac issues; namely training in the use of pharmaceuticals for cardiac and other health issues;Pharmaceutical preparations for the treatment of cardiac disease, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation; medicinal preparations for cardiac disease, namely, single ventricle heart disease (SVHD); pharmaceuticals, namely, drugs for the treatment of cardiac disease, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation;The wording WEKORO has no meaning in a foreign language.;

ZOLVERTA

Pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; pharmaceuticals and medicines for the sensory organs; pharmaceuticals and medicines for the central nervous system; pharmaceuticals and medicines for the urogenital organs; pharmaceuticals and medicines for the circulatory systems; pharmaceuticals and medicines for the treatment of cardiovascular and blood pressure;

ZYDENA

Pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; pharmaceuticals and medicines for the sensory organs; pharmaceuticals and medicines for the central nervous system; pharmaceuticals and medicines for the urogenital organs; pharmaceuticals and medicines for the circulatory systems; pharmaceuticals and medicines for the treatment of cardiovascular and blood pressure;